A study involving 38 SOT CMV sero-positive recipients showed that patients with a higher number of HCMV-specific CD4+ T cells detected prior to transplantation were more likely to have earlier immune restoration and less likely to have HCMV infections requiring anti-viral treatment (Gerna et al., 2006). This evidence concerns the gene CD4 and cytomegalovirus infection.